David R. Knop

1.6k total citations
23 papers, 1.2k citations indexed

About

David R. Knop is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, David R. Knop has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Genetics and 14 papers in Epidemiology. Recurrent topics in David R. Knop's work include Virus-based gene therapy research (14 papers), Herpesvirus Infections and Treatments (13 papers) and Retinal Development and Disorders (8 papers). David R. Knop is often cited by papers focused on Virus-based gene therapy research (14 papers), Herpesvirus Infections and Treatments (13 papers) and Retinal Development and Disorders (8 papers). David R. Knop collaborates with scholars based in United States, Switzerland and Israel. David R. Knop's co-authors include J. W. Frost, K. M. Draths, Jeffrey D. Chulay, Barry J. Byrne, Nathalie Clément, Guojie Ye, Guo-jie Ye, Margaret Humphries, Roberto Calcedo and Terence R. Flotte and has published in prestigious journals such as Journal of the American Chemical Society, Molecular Therapy and Gene Therapy.

In The Last Decade

David R. Knop

22 papers receiving 1.1k citations

Peers

Countries citing papers authored by David R. Knop

Since Specialization

Citations

This map shows the geographic impact of David R. Knop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Knop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Knop more than expected).

Fields of papers citing papers by David R. Knop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Knop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Knop. The network helps show where David R. Knop may publish in the future.

Co-authorship network of co-authors of David R. Knop

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Knop. A scholar is included among the top collaborators of David R. Knop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Knop. David R. Knop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dose Range Finding Studies with Two RPGR Transgenes in a Canine Model of X-Linked Retinitis Pigmentosa Treated with Subretinal Gene Therapy 2020 ·Human Gene Therapy ·Chunjuan Song, Valérie Dufour, Artur V. Cideciyan, Guojie Ye, Małgorzata Świder, Judith A. Newmark, Adrian M. Timmers, Paulette M. Robinson, David R. Knop, Jeffrey D. Chulay, Samuel G. Jacobson, Geoffrey K. Aguirre, William A. Beltran, Mark S. Shearman	18
2	Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized RPGR Delivered by Subretinal Injection in a Canine Model of X-linked Retinitis Pigmentosa 2020 ·Human Gene Therapy ·Valérie Dufour, Artur V. Cideciyan, Guojie Ye, Chunjuan Song, Adrian M. Timmers, Perry L. Habecker, Wei Pan, Nicole M. Weinstein, Małgorzata Świder, Amy C. Durham, Gui‐Shuang Ying, Paulette M. Robinson, Samuel G. Jacobson, David R. Knop, Jeffrey D. Chulay, Mark S. Shearman, Geoffrey K. Aguirre, William A. Beltran	30
3	Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid 2019 ·Human Gene Therapy ·Adrian M. Timmers, Judith A. Newmark, Heikki Turunen, (unknown), Jilin Liu, Chunjuan Song, Guojie Ye, Steven Pennock, (unknown), David R. Knop, Mark S. Shearman	66
4	Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice 2018 ·PubMed ·Chunjuan Song, Thomas J. Conlon, Wen‐Tao Deng, Kirsten E. Coleman, Ping Zhu, (unknown), (unknown), (unknown), Kari B. Green, (unknown), Alok Sharma, Adrian M. Timmers, Paulette M. Robinson, David R. Knop, William W. Hauswirth, Jeffrey D. Chulay, Mark S. Shearman, Guojie Ye	16
5	Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep 2017 ·PubMed ·E. Gootwine, Ron Ofri, Eyal Banin, Alexey Obolensky, Edward Averbukh, (unknown), (unknown), Hen Honig, Alexander Rosov, (unknown), Guojie Ye, David R. Knop, Paulette M. Robinson, Jeffrey D. Chulay, Mark S. Shearman	30
6	Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia 2016 ·Guo-jie Ye, Ewa Budzynski, (unknown), T. Michael Nork, P. Elliott Miller, (unknown), James N. Ver Hoeve, Leia M. Smith, (unknown), Roberto Calcedo, (unknown), Paulette M. Robinson, David R. Knop, William W. Hauswirth, Jeffrey D. Chulay	1
7	Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia 2016 ·PubMed ·Guo-jie Ye, Ewa Budzynski, (unknown), T. Michael Nork, Paul E. Miller, (unknown), James N. Ver Hoeve, Leia M. Smith, (unknown), (unknown), Paulette M. Robinson, Roberto Calcedo, David R. Knop, William W. Hauswirth, Jeffrey D. Chulay	20
8	Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia 2016 ·PubMed ·Guo-jie Ye, Ewa Budzynski, (unknown), T. Michael Nork, Paul E. Miller, Alok Sharma, James N. Ver Hoeve, Leia M. Smith, (unknown), Roberto Calcedo, (unknown), Paulette M. Robinson, David R. Knop, William W. Hauswirth, Jeffrey D. Chulay	53
9	Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin 2015 ·PubMed ·Guojie Ye, Ewa Budzynski, (unknown), P. Elliott Miller, Alok Sharma, James N. Ver Hoeve, (unknown), David R. Knop, Martha Neuringer, Trevor J. McGill, Jonathan Stoddard, Jeffrey D. Chulay	46
10	Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice 2015 ·PubMed ·Guojie Ye, Thomas J. Conlon, Kirsten Erger, (unknown), Alok Sharma, (unknown), David R. Knop, Jeffrey D. Chulay	20
11	Herpes Simplex Virus Clearance During Purification of a Recombinant Adeno-Associated Virus Serotype 1 Vector 2014 ·PubMed ·Guo-jie Ye, Marina M. Scotti, Darby L. Thomas, Lijun Wang, David R. Knop, Jeffrey D. Chulay	16
12	Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α ₁ -Antitrypsin: Interim Results 2011 ·Human Gene Therapy ·Terence R. Flotte, Bruce C. Trapnell, Margaret Humphries, Brenna Carey, Roberto Calcedo, Farshid N. Rouhani, Martha Campbell‐Thompson, Anthony T. Yachnis, Robert A. Sandhaus, Noel G. McElvaney, Christian Mueller, Louis M. Messina, James M. Wilson, Mark Brantly, David R. Knop, Guo-jie Ye, Jeffrey D. Chulay	265
13	Preclinical Evaluation of a Recombinant Adeno-Associated Virus Vector Expressing Human Alpha-1 Antitrypsin Made Using a Recombinant Herpes Simplex Virus Production Method 2010 ·Human Gene Therapy ·Jeffrey D. Chulay, (unknown), Darby L. Thomas, David R. Knop, Janet M. Benson, Julie A. Hutt, (unknown), Margaret Humphries, Terence R. Flotte	48
14	Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system 2010 ·Gene Therapy ·(unknown), Marina M. Scotti, (unknown), (unknown), David R. Knop, Gábor Veres	18
15	Scalable Recombinant Adeno-Associated Virus Production Using Recombinant Herpes Simplex Virus Type 1 Coinfection of Suspension-Adapted Mammalian Cells 2009 ·Human Gene Therapy ·Darby L. Thomas, Lijun Wang, (unknown), Jilin Liu, Wen Kang, Marina M. Scotti, Guojie Ye, Gábor Veres, David R. Knop	73
16	Large-Scale Adeno-Associated Viral Vector Production Using a Herpesvirus-Based System Enables Manufacturing for Clinical Studies 2009 ·Human Gene Therapy ·Nathalie Clément, David R. Knop, Barry J. Byrne	85
17	Beeinflußt die einmalige orale Einnahme von Famotidin den Blutalkoholspiegel? 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Gerald Holtmann, David R. Knop, Sven Becker, Manfred V. Singer	0
18	An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes 2008 ·Gene Therapy ·Wen Kang, (unknown), (unknown), (unknown), D. Thomas, (unknown), Marina M. Scotti, (unknown), Gábor Veres, David R. Knop	45
19	Bioreactor Production of Recombinant Herpes Simplex Virus Vectors 2007 ·Biotechnology Progress ·David R. Knop, (unknown)	23
20	503. A Novel Herpes Simplex Virus Helper Based Production of Adeno- Associated Virus Vectors for Treatment of Retinal Angiogenesis 2006 ·Molecular Therapy ·Guo-jie Ye, Chris Drogemuller, Darby L. Thomas, Marina M. Scotti, Wen Kang, David R. Knop, Sanford L. Boye, Peter Pecháň, Jim Peterson, William W. Hauswirth, Abraham Scaria, Samuel C. Wadsworth	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact